bioRxiv ScienceSearch

Biology subjects

Krista Fischer

Publications and source records attributed to Krista Fischer.

2 recordsLinked to original sources

Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms

Genetic variants affecting hematopoiesis can influence commonly measured blood cell traits. To identify factors that affect hematopoiesis, we performed association studies for blood cell traits in the population-based Estonian Biobank using high coverage whole genome sequencing (WGS) in 2,284 samples and SNP genotyping in an additional ~17,000 samples. Our analyses identified 17 associations across 14 blood cell traits. Integration of WGS-based fine-mapping and complementary epigenomic data sets provided evidence for causal mechanisms at several loci, including at a novel basophil count-associated locus near the master hematopoietic transcription factor CEBPA. The fine-mapped variant at this basophil count association near CEBPA overlapped an enhancer active in common myeloid progenitors and influenced its activity. In situ perturbation of this enhancer by CRISPR/Cas9 mutagenesis in hematopoietic stem and progenitor cells demonstrated that it is necessary for and specifically regulates CEBPA expression during basophil differentiation. We additionally identified basophil count-associated variation at another more pleiotropic myeloid enhancer near GATA2, highlighting regulatory mechanisms for ordered expression of master hematopoietic regulators during lineage specification. Our study illustrates how population-based genetic studies can provide key insights into poorly understood cell differentiation processes of considerable physiologic relevance.

Genetics

Personalized Risk Prediction for Type 2 Diabetes: the Potential of Genetic Risk Scores

PurposeThe study aims to develop a Genetic Risk Score (GRS) for the prediction of Type 2 Diabetes (T2D) that could be used for risk assessment in general population.\n\nMethodsUsing the results of genome-wide association studies, we develop a doubly-weighted GRS for the prediction of T2D risk, aiming to capture the effect of 1000 single nucleotide polymorphisms. The GRS is evaluated in the Estonian Biobank cohort (n=10273), analysing its effect on prevalent and incident T2D, while adjusting for other predictors. We assessed the effect of GRS on all-cause and cardiovascular mortality and its association with other T2D risk factors, and conducted the reclassification analysis.\n\nResultsThe adjusted hazard for incident T2D is 1.90 (95% CI 1.48, 2.44) times higher and for cardiovascular mortality 1.27 (95% CI 1.10, 1.46) times higher in the highest GRS quintile compared to the rest of the cohort. No significant association between BMI and GRS is found in T2D-free individuals. Adding GRS to the prediction model for 5-year T2D risks results in continuous Net Reclassification Improvement of 0.26 (95% CI 0.15, 0.38).\n\nConclusionThe proposed GRS would considerably improve the accuracy of T2D risk prediction when added to the set of predictors used so far.

Genetics